Erytech Pharma SA (ERYP) has fallen Friday morning, with the stock losing -1.18% in pre-market trading to 2.51. ERYP's short-term technical score of 25 indicates that the stock has traded less bullishly over the last month than 75% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, Erytech Pharma SA ranks higher than 48% of stocks. Erytech Pharma SA has fallen 12.71% over the past month, closing at $2.46 on November 5. During this period of time, the stock fell as low as $2.30 and as high as $2.99. ERYP has an average analyst recommendation of Sell. The company has an average price target of $3.20.
Erytech Pharma SA has a Long-Term Technical rank of 2. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 98% of the market scoring higher. In the Biotechnology industry which is number 140 by this metric, ERYP ranks better than 6% of stocks.
Premarket Mover: Erytech Pharma SA (ERYP) Down 1.18%
ERYP has an Overall Score of 21. Find out what this means to you and get the rest of the rankings on ERYP!